| Genetic and functional drivers of diffuse large B cell lymphoma A Reddy, J Zhang, NS Davis, AB Moffitt, CL Love, A Waldrop, S Leppa, ... Cell 171 (2), 481-494. e15, 2017 | 987 | 2017 |
| Diffuse large B-cell lymphoma S Li, KH Young, LJ Medeiros Pathology 50 (1), 74-87, 2018 | 629 | 2018 |
| Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis AM Petrich, M Gandhi, B Jovanovic, JJ Castillo, S Rajguru, DT Yang, ... Blood, The Journal of the American Society of Hematology 124 (15), 2354-2361, 2014 | 519 | 2014 |
| B-cell lymphomas with MYC/8q24 rearrangements and IGH@ BCL2/t (14; 18)(q32; q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and … S Li, P Lin, LE Fayad, PA Lennon, RN Miranda, CC Yin, E Lin, ... Modern pathology 25 (1), 145-156, 2012 | 303 | 2012 |
| Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center S Li, X Feng, T Li, S Zhang, Z Zuo, P Lin, S Konoplev, CE Bueso-Ramos, ... The American journal of surgical pathology 37 (1), 14-23, 2013 | 242 | 2013 |
| Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial ML Wang, H Lee, H Chuang, N Wagner-Bartak, F Hagemeister, J Westin, ... The Lancet Oncology 17 (1), 48-56, 2016 | 232 | 2016 |
| Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai–Dorfman disease S Garces, LJ Medeiros, KP Patel, S Li, S Pina-Oviedo, J Li, JC Garces, ... Modern Pathology 30 (10), 1367-1377, 2017 | 206 | 2017 |
| Outcomes of patients with double-hit lymphoma who achieve first complete remission DJ Landsburg, MK Falkiewicz, J Maly, KA Blum, C Howlett, T Feldman, ... Journal of Clinical Oncology 35 (20), 2260, 2017 | 164 | 2017 |
| Additive manufacturing of polymeric composites from material processing to structural design S Yuan, S Li, J Zhu, Y Tang Composites Part B: Engineering 219, 108903, 2021 | 138 | 2021 |
| MYC/BCL6 double‐hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis S Li, P Desai, P Lin, CC Yin, G Tang, XJ Wang, SN Konoplev, JD Khoury, ... Histopathology 68 (7), 1090-1098, 2016 | 115 | 2016 |
| Pyk2 activation is integral to acid stimulation of sodium/hydrogen exchanger 3 S Li, S Sato, X Yang, PA Preisig, RJ Alpern The Journal of clinical investigation 114 (12), 1782-1789, 2004 | 111 | 2004 |
| Concurrent topology optimization design of structures and non-uniform parameterized lattice microstructures C Wang, JH Zhu, WH Zhang, SY Li, J Kong Structural and Multidisciplinary Optimization 58, 35-50, 2018 | 107 | 2018 |
| B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas S Li, AC Seegmiller, P Lin, XJ Wang, RN Miranda, S Bhagavathi, ... Modern pathology 28 (2), 208-217, 2015 | 103 | 2015 |
| Long‐term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib P Jain, R Kanagal‐Shamanna, S Zhang, M Ahmed, A Ghorab, L Zhang, ... British journal of haematology 183 (4), 578-587, 2018 | 98 | 2018 |
| Concurrent design of hierarchical structures with three-dimensional parameterized lattice microstructures for additive manufacturing C Wang, X Gu, J Zhu, H Zhou, S Li, W Zhang Structural and Multidisciplinary Optimization 61, 869-894, 2020 | 92 | 2020 |
| MYC/BCL2 double-hit high-grade B-cell lymphoma S Li, P Lin, KH Young, R Kanagal-Shamanna, CC Yin, LJ Medeiros Advances in anatomic pathology 20 (5), 315-326, 2013 | 89 | 2013 |
| P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B … XJ Wang, L Jeffrey Medeiros, CE Bueso-Ramos, G Tang, S Wang, Y Oki, ... Modern Pathology 30 (2), 194-203, 2017 | 88 | 2017 |
| Survival outcomes of younger patients with mantle cell lymphoma treated in the rituximab era JN Gerson, E Handorf, D Villa, AS Gerrie, P Chapani, S Li, LJ Medeiros, ... Journal of Clinical Oncology 37 (6), 471-480, 2019 | 87 | 2019 |
| Additive manufacturing-driven design optimization: Building direction and structural topology S Li, S Yuan, J Zhu, C Wang, J Li, W Zhang Additive Manufacturing 36, 101406, 2020 | 84 | 2020 |
| BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases K Alayed, LJ Medeiros, KP Patel, Z Zuo, S Li, S Verma, J Galbincea, ... Human Pathology 52, 61-67, 2016 | 79 | 2016 |
